Impaired coronary flow reserve in young patients affected by severe psoriasis

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 113-117

  Osto, Elena ^a   Piaserico, Stefano ^a   Maddalozzo, Anna ^a   Forchetti, Giulia ^a   Montisci, Roberta ^b   Famoso, Giulia ^a   Giovagnoni, Andrea ^c   Peserico, Andrea ^a   Iliceto, Sabino ^a   Tona, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Abano Terme Hospital   (Italy)

Author keywords

Coronary flow reserve; Inflammation; Microcirculation; Psoriasis; Risk factors

Indexed keywords

CYCLOSPORIN; ETRETIN; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; REPRODUCIBILITY; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION;

ADENOSINE; ADULT; ANTI-INFLAMMATORY AGENTS; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; HYPEREMIA; ITALY; LINEAR MODELS; LOGISTIC MODELS; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PSORIASIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASODILATOR AGENTS;

EID: 84857034652     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.015     Document Type: Article

References (23)

1. Nestle F.O., Kaplan D.H., Psoriasis B.J. N Engl J Med 2009, 361:496-509.
2. Elder J.T., Bruce A.T., Gudjonsson J.E., et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 2010, 130:1213-1226.
3. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
4. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B. Risk of myocardial infarction in patients with psoriasis. JAMA 2006, 296:1735-1741.
5. Friedewald V.E., Cather J.C., Gelfand J.M., et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 2008, 102:1631-1643.
6. Fredriksson T., Pettersson U. Oral treatment of pustulosis palmo-plantaris with a new retinoid, Ro10-9359. Dermatologica 1979, 158:60-64.
7. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
8. Nishimura R.A., Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997, 30:8-18.
9. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
10. Nagueh S.F., Appleton C.P., Gillebert T.C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009, 22:107-133.
11. Tona F., Caforio A.L.P., Montisci R., et al. Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation 2006, 114(Suppl. I):I-49-I-55.
12. Rubinshtein R., Yang E.H., Rihal C.S., et al. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J 2009, 31:936-942.
13. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease, Council on Cardiovascular Surgery, Dallas, TX: American Heart Association. Circulation 1975, 51:35-40.
14. Ishimori M.L., Martin R., Berman D.S., et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. J Am Coll Cardiol Imaging 2011, 4:27-33.
15. Bremmer S., Van Voorhees A.S., Hsu S., et al. National Psoriasis Foundation. J Am Acad Dermatol 2010, 63:1058-1069.
16. Paul C., Gourraud P.A., Bronsard V., et al. Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 2010, 24(Suppl 2):2-9.
17. Coimbra S., Oliveira H., Reis F., et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010, 24:789-796.
18. Takahashi H., Tsuji H., Hashimoto Y., Ishida-Yamamoto A., Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2010, 35:645-649.
19. Libby P., Crea F. Clinical implications of inflammation for cardiovascular primary prevention. Eur Heart J 2010, 31:777-783.
20. Morsy H., Kamp S., Thrane L., et al. Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity. Arch Dermatol Res 2010, 302:105-111.
21. Nakai K., Yoneda K., Maeda R., et al. Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis. J Eur Acad Dermatol Venereol 2009, 23:1405-1408.
22. Vaccarino V., Khan D., Votaw J., et al. Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins. J Am Coll Cardiol 2011, 57:1271-1279.
23. Kleinbongard P., Heusch G., Schulz R. TNF-alpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 2010, 127:295-314.